Global Wilson's Disease Market Research Report 2024

Wilson's Disease Market

Wilson’s disease is also known as progressive lenticular degeneration and hepatolenticular degeneration that causes copper poisoning in the body. Copper is a necessary element for cellular functions; however, excessive copper is extremely toxic and can cause permanent damage to cellular functions of body. Wilson’s disease is caused by excessive deposition of copper in the body. Generally, copper is released into bile from the diet is cleaned out by the liver, flowing out of the body from the gastrointestinal tract. Wilson’s disease occurs due to excessive deposition of copper in the brain, liver, and other tissues of the body. According to the American Association for the Study of Liver Diseases, Wilson’s disease occurs worldwide with prevalence of approximately 30 individuals affected per million.

The classification of Wilson’s disease includes Trientine, Penicillamine and others, and the proportion of Trientine in 2019 is about 47%. Penicillamine was the first drug approved for the treatment of Wilson’s disease. Penicillamine is the most successful drug used for the treatment of Wilson’s disease. Wilson’s disease is widely used in Hospital, drugs stores and other field. The most proportion of Wilson’s disease is Drugs Store, and the proportion in 2019 is 51%. North America is the largest consumption place, with a consumption market share nearly 76.93% in 2019. Following North America, Europe is the second largest consumption place with the consumption market share of 10.51%. Market competition is intense. Bausch Health, Teva, Endo International, Univar Solutions, MSN Laboratories, etc. are the leaders of the industry.

This report aims to provide a comprehensive presentation of the global market for Wilson's Disease, with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Wilson's Disease.

Report Scope

The Wilson's Disease market size, estimations, and forecasts are provided in terms of revenue ($ millions), considering 2023 as the base year, with history and forecast data for the period from 2019 to 2030. This report segments the global Wilson's Disease market comprehensively. Regional market sizes, concerning products by Type, by Application, and by players, are also provided.

For a more in-depth understanding of the market, the report provides profiles of the competitive landscape, key competitors, and their respective market ranks. The report also discusses technological trends and new product developments.

The report will help the Wilson's Disease companies, new entrants, and industry chain related companies in this market with information on the revenues, sales volume, and average price for the overall market and the sub-segments across the different segments, by company, by Type, by Application, and by regions.

Market Segmentation

Bausch Health

Teva

Endo International

Univar Solutions

MSN Laboratories

ANI Pharmaceuticals

APOTEX

Tsumura

Sinepharm

Taj Pharmaceutical

Kadmon Holdings

Trientine

Penicillamine

Others

Hospital

Drugs Stores

Others

North America

United States

Canada

Europe

Germany

France

UK

Italy

Russia

Nordic Countries

Rest of Europe

Asia-Pacific

China

Japan

South Korea

Southeast Asia

India

Australia

Rest of Asia

Latin America

Mexico

Brazil

Rest of Latin America

Middle East & Africa

Turkey

Saudi Arabia

UAE

Rest of MEA

Scope of Wilson's Disease Market Report

Chapter Outline

Chapter 1: Introduces the report scope of the report, executive summary of different market segments (by Type, by Application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.

Chapter 2: Introduces executive summary of global market size, regional market size, this section also introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by companies in the industry, and the analysis of relevant policies in the industry.

Chapter 3: Detailed analysis of Wilson's Disease companies’ competitive landscape, revenue market share, latest development plan, merger, and acquisition information, etc.

Chapter 4: Provides the analysis of various market segments by Type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.

Chapter 5: Provides the analysis of various market segments by Application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.

Chapter 6, 7, 8, 9, 10: North America, Europe, Asia Pacific, Latin America, Middle East and Africa segment by country. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and capacity of each country in the world.

Chapter 11: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.

Chapter 12: The main points and conclusions of the report.

1.1 Study Scope

1.2 Market Analysis by Type

1.2.1 Global Wilson's Disease Market Size Growth Rate by Type: 2019 VS 2023 VS 2030

1.2.2 Trientine

1.2.3 Penicillamine

1.2.4 Others

1.3 Market by Application

1.3.1 Global Wilson's Disease Market Growth by Application: 2019 VS 2023 VS 2030

1.3.2 Hospital

1.3.3 Drugs Stores

1.3.4 Others

1.4 Study Objectives

1.5 Years Considered

1.6 Years Considered

2.1 Global Wilson's Disease Market Perspective (2019-2030)

2.2 Wilson's Disease Growth Trends by Region

2.2.1 Global Wilson's Disease Market Size by Region: 2019 VS 2023 VS 2030

2.2.2 Wilson's Disease Historic Market Size by Region (2019-2024)

2.2.3 Wilson's Disease Forecasted Market Size by Region (2025-2030)

2.3 Wilson's Disease Market Dynamics

2.3.1 Wilson's Disease Industry Trends

2.3.2 Wilson's Disease Market Drivers

2.3.3 Wilson's Disease Market Challenges

2.3.4 Wilson's Disease Market Restraints

3.1 Global Top Wilson's Disease Players by Revenue

3.1.1 Global Top Wilson's Disease Players by Revenue (2019-2024)

3.1.2 Global Wilson's Disease Revenue Market Share by Players (2019-2024)

3.2 Global Wilson's Disease Market Share by Company Type (Tier 1, Tier 2, and Tier 3)

3.3 Players Covered: Ranking by Wilson's Disease Revenue

3.4 Global Wilson's Disease Market Concentration Ratio

3.4.1 Global Wilson's Disease Market Concentration Ratio (CR5 and HHI)

3.4.2 Global Top 10 and Top 5 Companies by Wilson's Disease Revenue in 2023

3.5 Wilson's Disease Key Players Head office and Area Served

3.6 Key Players Wilson's Disease Product Solution and Service

3.7 Date of Enter into Wilson's Disease Market

3.8 Mergers & Acquisitions, Expansion Plans

4.1 Global Wilson's Disease Historic Market Size by Type (2019-2024)

4.2 Global Wilson's Disease Forecasted Market Size by Type (2025-2030)

5.1 Global Wilson's Disease Historic Market Size by Application (2019-2024)

5.2 Global Wilson's Disease Forecasted Market Size by Application (2025-2030)

6.1 North America Wilson's Disease Market Size (2019-2030)

6.2 North America Wilson's Disease Market Growth Rate by Country: 2019 VS 2023 VS 2030

6.3 North America Wilson's Disease Market Size by Country (2019-2024)

6.4 North America Wilson's Disease Market Size by Country (2025-2030)

6.5 United States

6.6 Canada

7.1 Europe Wilson's Disease Market Size (2019-2030)

7.2 Europe Wilson's Disease Market Growth Rate by Country: 2019 VS 2023 VS 2030

7.3 Europe Wilson's Disease Market Size by Country (2019-2024)

7.4 Europe Wilson's Disease Market Size by Country (2025-2030)

7.5 Germany

7.6 France

7.7 U.K.

7.8 Italy

7.9 Russia

7.10 Nordic Countries

8.1 Asia-Pacific Wilson's Disease Market Size (2019-2030)

8.2 Asia-Pacific Wilson's Disease Market Growth Rate by Region: 2019 VS 2023 VS 2030

8.3 Asia-Pacific Wilson's Disease Market Size by Region (2019-2024)

8.4 Asia-Pacific Wilson's Disease Market Size by Region (2025-2030)

8.5 China

8.6 Japan

8.7 South Korea

8.8 Southeast Asia

8.9 India

8.10 Australia

9.1 Latin America Wilson's Disease Market Size (2019-2030)

9.2 Latin America Wilson's Disease Market Growth Rate by Country: 2019 VS 2023 VS 2030

9.3 Latin America Wilson's Disease Market Size by Country (2019-2024)

9.4 Latin America Wilson's Disease Market Size by Country (2025-2030)

9.5 Mexico

9.6 Brazil

10.1 Middle East & Africa Wilson's Disease Market Size (2019-2030)

10.2 Middle East & Africa Wilson's Disease Market Growth Rate by Country: 2019 VS 2023 VS 2030

10.3 Middle East & Africa Wilson's Disease Market Size by Country (2019-2024)

10.4 Middle East & Africa Wilson's Disease Market Size by Country (2025-2030)

10.5 Turkey

10.6 Saudi Arabia

10.7 UAE

11.1 Bausch Health

11.1.1 Bausch Health Company Detail

11.1.2 Bausch Health Business Overview

11.1.3 Bausch Health Wilson's Disease Introduction

11.1.4 Bausch Health Revenue in Wilson's Disease Business (2019-2024)

11.1.5 Bausch Health Recent Development

11.2 Teva

11.2.1 Teva Company Detail

11.2.2 Teva Business Overview

11.2.3 Teva Wilson's Disease Introduction

11.2.4 Teva Revenue in Wilson's Disease Business (2019-2024)

11.2.5 Teva Recent Development

11.3 Endo International

11.3.1 Endo International Company Detail

11.3.2 Endo International Business Overview

11.3.3 Endo International Wilson's Disease Introduction

11.3.4 Endo International Revenue in Wilson's Disease Business (2019-2024)

11.3.5 Endo International Recent Development

11.4 Univar Solutions

11.4.1 Univar Solutions Company Detail

11.4.2 Univar Solutions Business Overview

11.4.3 Univar Solutions Wilson's Disease Introduction

11.4.4 Univar Solutions Revenue in Wilson's Disease Business (2019-2024)

11.4.5 Univar Solutions Recent Development

11.5 MSN Laboratories

11.5.1 MSN Laboratories Company Detail

11.5.2 MSN Laboratories Business Overview

11.5.3 MSN Laboratories Wilson's Disease Introduction

11.5.4 MSN Laboratories Revenue in Wilson's Disease Business (2019-2024)

11.5.5 MSN Laboratories Recent Development

11.6 ANI Pharmaceuticals

11.6.1 ANI Pharmaceuticals Company Detail

11.6.2 ANI Pharmaceuticals Business Overview

11.6.3 ANI Pharmaceuticals Wilson's Disease Introduction

11.6.4 ANI Pharmaceuticals Revenue in Wilson's Disease Business (2019-2024)

11.6.5 ANI Pharmaceuticals Recent Development

11.7 APOTEX

11.7.1 APOTEX Company Detail

11.7.2 APOTEX Business Overview

11.7.3 APOTEX Wilson's Disease Introduction

11.7.4 APOTEX Revenue in Wilson's Disease Business (2019-2024)

11.7.5 APOTEX Recent Development

11.8 Tsumura

11.8.1 Tsumura Company Detail

11.8.2 Tsumura Business Overview

11.8.3 Tsumura Wilson's Disease Introduction

11.8.4 Tsumura Revenue in Wilson's Disease Business (2019-2024)

11.8.5 Tsumura Recent Development

11.9 Sinepharm

11.9.1 Sinepharm Company Detail

11.9.2 Sinepharm Business Overview

11.9.3 Sinepharm Wilson's Disease Introduction

11.9.4 Sinepharm Revenue in Wilson's Disease Business (2019-2024)

11.9.5 Sinepharm Recent Development

11.10 Taj Pharmaceutical

11.10.1 Taj Pharmaceutical Company Detail

11.10.2 Taj Pharmaceutical Business Overview

11.10.3 Taj Pharmaceutical Wilson's Disease Introduction

11.10.4 Taj Pharmaceutical Revenue in Wilson's Disease Business (2019-2024)

11.10.5 Taj Pharmaceutical Recent Development

11.11 Kadmon Holdings

11.11.1 Kadmon Holdings Company Detail

11.11.2 Kadmon Holdings Business Overview

11.11.3 Kadmon Holdings Wilson's Disease Introduction

11.11.4 Kadmon Holdings Revenue in Wilson's Disease Business (2019-2024)

11.11.5 Kadmon Holdings Recent Development

13.1 Research Methodology

13.1.1 Methodology/Research Approach

13.1.2 Data Source

13.2 Disclaimer

13.3 Author Details

List of Tables

    Table 1. Global Wilson's Disease Market Size Growth Rate by Type (US$ Million): 2019 VS 2023 VS 2030

    Table 2. Key Players of Trientine

    Table 3. Key Players of Penicillamine

    Table 4. Key Players of Others

    Table 5. Global Wilson's Disease Market Size Growth by Application (US$ Million): 2019 VS 2023 VS 2030

    Table 6. Global Wilson's Disease Market Size by Region (US$ Million): 2019 VS 2023 VS 2030

    Table 7. Global Wilson's Disease Market Size by Region (2019-2024) & (US$ Million)

    Table 8. Global Wilson's Disease Market Share by Region (2019-2024)

    Table 9. Global Wilson's Disease Forecasted Market Size by Region (2025-2030) & (US$ Million)

    Table 10. Global Wilson's Disease Market Share by Region (2025-2030)

    Table 11. Wilson's Disease Market Trends

    Table 12. Wilson's Disease Market Drivers

    Table 13. Wilson's Disease Market Challenges

    Table 14. Wilson's Disease Market Restraints

    Table 15. Global Wilson's Disease Revenue by Players (2019-2024) & (US$ Million)

    Table 16. Global Wilson's Disease Market Share by Players (2019-2024)

    Table 17. Global Top Wilson's Disease Players by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Wilson's Disease as of 2023)

    Table 18. Ranking of Global Top Wilson's Disease Companies by Revenue (US$ Million) in 2023

    Table 19. Global 5 Largest Players Market Share by Wilson's Disease Revenue (CR5 and HHI) & (2019-2024)

    Table 20. Key Players Headquarters and Area Served

    Table 21. Key Players Wilson's Disease Product Solution and Service

    Table 22. Date of Enter into Wilson's Disease Market

    Table 23. Mergers & Acquisitions, Expansion Plans

    Table 24. Global Wilson's Disease Market Size by Type (2019-2024) & (US$ Million)

    Table 25. Global Wilson's Disease Revenue Market Share by Type (2019-2024)

    Table 26. Global Wilson's Disease Forecasted Market Size by Type (2025-2030) & (US$ Million)

    Table 27. Global Wilson's Disease Revenue Market Share by Type (2025-2030)

    Table 28. Global Wilson's Disease Market Size by Application (2019-2024) & (US$ Million)

    Table 29. Global Wilson's Disease Revenue Market Share by Application (2019-2024)

    Table 30. Global Wilson's Disease Forecasted Market Size by Application (2025-2030) & (US$ Million)

    Table 31. Global Wilson's Disease Revenue Market Share by Application (2025-2030)

    Table 32. North America Wilson's Disease Market Size Growth Rate by Country (US$ Million): 2019 VS 2023 VS 2030

    Table 33. North America Wilson's Disease Market Size by Country (2019-2024) & (US$ Million)

    Table 34. North America Wilson's Disease Market Size by Country (2025-2030) & (US$ Million)

    Table 35. Europe Wilson's Disease Market Size Growth Rate by Country (US$ Million): 2019 VS 2023 VS 2030

    Table 36. Europe Wilson's Disease Market Size by Country (2019-2024) & (US$ Million)

    Table 37. Europe Wilson's Disease Market Size by Country (2025-2030) & (US$ Million)

    Table 38. Asia-Pacific Wilson's Disease Market Size Growth Rate by Region (US$ Million): 2019 VS 2023 VS 2030

    Table 39. Asia-Pacific Wilson's Disease Market Size by Region (2019-2024) & (US$ Million)

    Table 40. Asia-Pacific Wilson's Disease Market Size by Region (2025-2030) & (US$ Million)

    Table 41. Latin America Wilson's Disease Market Size Growth Rate by Country (US$ Million): 2019 VS 2023 VS 2030

    Table 42. Latin America Wilson's Disease Market Size by Country (2019-2024) & (US$ Million)

    Table 43. Latin America Wilson's Disease Market Size by Country (2025-2030) & (US$ Million)

    Table 44. Middle East & Africa Wilson's Disease Market Size Growth Rate by Country (US$ Million): 2019 VS 2023 VS 2030

    Table 45. Middle East & Africa Wilson's Disease Market Size by Country (2019-2024) & (US$ Million)

    Table 46. Middle East & Africa Wilson's Disease Market Size by Country (2025-2030) & (US$ Million)

    Table 47. Bausch Health Company Detail

    Table 48. Bausch Health Business Overview

    Table 49. Bausch Health Wilson's Disease Product

    Table 50. Bausch Health Revenue in Wilson's Disease Business (2019-2024) & (US$ Million)

    Table 51. Bausch Health Recent Development

    Table 52. Teva Company Detail

    Table 53. Teva Business Overview

    Table 54. Teva Wilson's Disease Product

    Table 55. Teva Revenue in Wilson's Disease Business (2019-2024) & (US$ Million)

    Table 56. Teva Recent Development

    Table 57. Endo International Company Detail

    Table 58. Endo International Business Overview

    Table 59. Endo International Wilson's Disease Product

    Table 60. Endo International Revenue in Wilson's Disease Business (2019-2024) & (US$ Million)

    Table 61. Endo International Recent Development

    Table 62. Univar Solutions Company Detail

    Table 63. Univar Solutions Business Overview

    Table 64. Univar Solutions Wilson's Disease Product

    Table 65. Univar Solutions Revenue in Wilson's Disease Business (2019-2024) & (US$ Million)

    Table 66. Univar Solutions Recent Development

    Table 67. MSN Laboratories Company Detail

    Table 68. MSN Laboratories Business Overview

    Table 69. MSN Laboratories Wilson's Disease Product

    Table 70. MSN Laboratories Revenue in Wilson's Disease Business (2019-2024) & (US$ Million)

    Table 71. MSN Laboratories Recent Development

    Table 72. ANI Pharmaceuticals Company Detail

    Table 73. ANI Pharmaceuticals Business Overview

    Table 74. ANI Pharmaceuticals Wilson's Disease Product

    Table 75. ANI Pharmaceuticals Revenue in Wilson's Disease Business (2019-2024) & (US$ Million)

    Table 76. ANI Pharmaceuticals Recent Development

    Table 77. APOTEX Company Detail

    Table 78. APOTEX Business Overview

    Table 79. APOTEX Wilson's Disease Product

    Table 80. APOTEX Revenue in Wilson's Disease Business (2019-2024) & (US$ Million)

    Table 81. APOTEX Recent Development

    Table 82. Tsumura Company Detail

    Table 83. Tsumura Business Overview

    Table 84. Tsumura Wilson's Disease Product

    Table 85. Tsumura Revenue in Wilson's Disease Business (2019-2024) & (US$ Million)

    Table 86. Tsumura Recent Development

    Table 87. Sinepharm Company Detail

    Table 88. Sinepharm Business Overview

    Table 89. Sinepharm Wilson's Disease Product

    Table 90. Sinepharm Revenue in Wilson's Disease Business (2019-2024) & (US$ Million)

    Table 91. Sinepharm Recent Development

    Table 92. Taj Pharmaceutical Company Detail

    Table 93. Taj Pharmaceutical Business Overview

    Table 94. Taj Pharmaceutical Wilson's Disease Product

    Table 95. Taj Pharmaceutical Revenue in Wilson's Disease Business (2019-2024) & (US$ Million)

    Table 96. Taj Pharmaceutical Recent Development

    Table 97. Kadmon Holdings Company Detail

    Table 98. Kadmon Holdings Business Overview

    Table 99. Kadmon Holdings Wilson's Disease Product

    Table 100. Kadmon Holdings Revenue in Wilson's Disease Business (2019-2024) & (US$ Million)

    Table 101. Kadmon Holdings Recent Development

    Table 102. Research Programs/Design for This Report

    Table 103. Key Data Information from Secondary Sources

    Table 104. Key Data Information from Primary Sources

List of Figures

    Figure 1. Global Wilson's Disease Market Size Comparison by Type (2024-2030) & (US$ Million)

    Figure 2. Global Wilson's Disease Market Share by Type: 2023 VS 2030

    Figure 3. Trientine Features

    Figure 4. Penicillamine Features

    Figure 5. Others Features

    Figure 6. Global Wilson's Disease Market Size Comparison by Application (2024-2030) & (US$ Million)

    Figure 7. Global Wilson's Disease Market Share by Application: 2023 VS 2030

    Figure 8. Hospital Case Studies

    Figure 9. Drugs Stores Case Studies

    Figure 10. Others Case Studies

    Figure 11. Wilson's Disease Report Years Considered

    Figure 12. Global Wilson's Disease Market Size (US$ Million), Year-over-Year: 2019-2030

    Figure 13. Global Wilson's Disease Market Size, (US$ Million), 2019 VS 2023 VS 2030

    Figure 14. Global Wilson's Disease Market Share by Region: 2023 VS 2030

    Figure 15. Global Wilson's Disease Market Share by Players in 2023

    Figure 16. Global Top Wilson's Disease Players by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Wilson's Disease as of 2023)

    Figure 17. The Top 10 and 5 Players Market Share by Wilson's Disease Revenue in 2023

    Figure 18. North America Wilson's Disease Market Size YoY Growth (2019-2030) & (US$ Million)

    Figure 19. North America Wilson's Disease Market Share by Country (2019-2030)

    Figure 20. United States Wilson's Disease Market Size YoY Growth (2019-2030) & (US$ Million)

    Figure 21. Canada Wilson's Disease Market Size YoY Growth (2019-2030) & (US$ Million)

    Figure 22. Europe Wilson's Disease Market Size YoY Growth (2019-2030) & (US$ Million)

    Figure 23. Europe Wilson's Disease Market Share by Country (2019-2030)

    Figure 24. Germany Wilson's Disease Market Size YoY Growth (2019-2030) & (US$ Million)

    Figure 25. France Wilson's Disease Market Size YoY Growth (2019-2030) & (US$ Million)

    Figure 26. U.K. Wilson's Disease Market Size YoY Growth (2019-2030) & (US$ Million)

    Figure 27. Italy Wilson's Disease Market Size YoY Growth (2019-2030) & (US$ Million)

    Figure 28. Russia Wilson's Disease Market Size YoY Growth (2019-2030) & (US$ Million)

    Figure 29. Nordic Countries Wilson's Disease Market Size YoY Growth (2019-2030) & (US$ Million)

    Figure 30. Asia-Pacific Wilson's Disease Market Size YoY Growth (2019-2030) & (US$ Million)

    Figure 31. Asia-Pacific Wilson's Disease Market Share by Region (2019-2030)

    Figure 32. China Wilson's Disease Market Size YoY Growth (2019-2030) & (US$ Million)

    Figure 33. Japan Wilson's Disease Market Size YoY Growth (2019-2030) & (US$ Million)

    Figure 34. South Korea Wilson's Disease Market Size YoY Growth (2019-2030) & (US$ Million)

    Figure 35. Southeast Asia Wilson's Disease Market Size YoY Growth (2019-2030) & (US$ Million)

    Figure 36. India Wilson's Disease Market Size YoY Growth (2019-2030) & (US$ Million)

    Figure 37. Australia Wilson's Disease Market Size YoY Growth (2019-2030) & (US$ Million)

    Figure 38. Latin America Wilson's Disease Market Size YoY Growth (2019-2030) & (US$ Million)

    Figure 39. Latin America Wilson's Disease Market Share by Country (2019-2030)

    Figure 40. Mexico Wilson's Disease Market Size YoY Growth (2019-2030) & (US$ Million)

    Figure 41. Brazil Wilson's Disease Market Size YoY Growth (2019-2030) & (US$ Million)

    Figure 42. Middle East & Africa Wilson's Disease Market Size YoY Growth (2019-2030) & (US$ Million)

    Figure 43. Middle East & Africa Wilson's Disease Market Share by Country (2019-2030)

    Figure 44. Turkey Wilson's Disease Market Size YoY Growth (2019-2030) & (US$ Million)

    Figure 45. Saudi Arabia Wilson's Disease Market Size YoY Growth (2019-2030) & (US$ Million)

    Figure 46. Bausch Health Revenue Growth Rate in Wilson's Disease Business (2019-2024)

    Figure 47. Teva Revenue Growth Rate in Wilson's Disease Business (2019-2024)

    Figure 48. Endo International Revenue Growth Rate in Wilson's Disease Business (2019-2024)

    Figure 49. Univar Solutions Revenue Growth Rate in Wilson's Disease Business (2019-2024)

    Figure 50. MSN Laboratories Revenue Growth Rate in Wilson's Disease Business (2019-2024)

    Figure 51. ANI Pharmaceuticals Revenue Growth Rate in Wilson's Disease Business (2019-2024)

    Figure 52. APOTEX Revenue Growth Rate in Wilson's Disease Business (2019-2024)

    Figure 53. Tsumura Revenue Growth Rate in Wilson's Disease Business (2019-2024)

    Figure 54. Sinepharm Revenue Growth Rate in Wilson's Disease Business (2019-2024)

    Figure 55. Taj Pharmaceutical Revenue Growth Rate in Wilson's Disease Business (2019-2024)

    Figure 56. Kadmon Holdings Revenue Growth Rate in Wilson's Disease Business (2019-2024)

    Figure 57. Bottom-up and Top-down Approaches for This Report

    Figure 58. Data Triangulation

    Figure 59. Key Executives Interviewed